These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 14228887)
21. ROLE OF DEBRIS OF TUMOUR ASCITIC FLUID IN TRANSPLANTATION IMMUNITY. HILGERT I; CASTERMANS A; LEJEUNE G; VRANKEN M Nature; 1964 Nov; 204():704-5. PubMed ID: 14236310 [No Abstract] [Full Text] [Related]
22. SOME PROPERTIES OF MOUSE HISTOCOMPATIBILITY ANTIGENS: H-2, NON-H-2, X (LEUKEMIC) AND Y (SEX LINKED). DAVIES DA Ann N Y Acad Sci; 1964 Nov; 120():230-6. PubMed ID: 14233869 [No Abstract] [Full Text] [Related]
23. DEMONSTRATION OF SYNGENEIC PREFERENCE IN VITRO. HELLSTROEM KE; HELLSTROEM I; HAUGHTON G Nature; 1964 Nov; 204():661-4. PubMed ID: 14236283 [No Abstract] [Full Text] [Related]
24. EMBRYOLOGICAL DEVELOPMENT OF THE IMMUNE MECHANISM. MILLER JF; DAVIES JS Annu Rev Med; 1964; 15():23-36. PubMed ID: 14133848 [No Abstract] [Full Text] [Related]
25. LOCAL SUBCUTANEOUS EOSINOPHIL LEUCOCYTIC REACTION TO THE INOCULATION OF ISOLATED NORMAL OR TUMOUR CELLS IN MICE. GOSWAMI PK Br J Cancer; 1964 Dec; 18(4):692-700. PubMed ID: 14264934 [No Abstract] [Full Text] [Related]
26. Neuraminidase induced immunospecific destruction of transplantable experimental tumors. Sethi KK; Teschner M Postepy Hig Med Dosw; 1974; 28(1):103-20. PubMed ID: 4816378 [No Abstract] [Full Text] [Related]
27. TRANSPLANT IMMUNITY TO POLYOMA VIRUS INDUCED TUMORS. 3. EVIDENCE FOR HETEROGENEITY AMONG TRANSPLANT ANTIGENS IN VIVO. HARE JD; GODAL T Proc Soc Exp Biol Med; 1965 Mar; 118():632-6. PubMed ID: 14264514 [No Abstract] [Full Text] [Related]
28. ISOANTIBODIES TO HUMAN CANCER CELLS IN CANCER PATIENTS FOLLOWING CANCER HOMOTRANSPLANTS. ITOH T; SOUTHAM CM J Immunol; 1964 Dec; 93():926-36. PubMed ID: 14241767 [No Abstract] [Full Text] [Related]
29. [THE PRODUCTION OF RESISTANCE AGAINST ISOLOGOUS TRANSPLANTS OF ULTRAVIOLET-INDUCED SARCOMA IN MICE]. GRAFFI A; PASTERNAK G; HORN KH Acta Biol Med Ger; 1964; 12():726-8. PubMed ID: 14242071 [No Abstract] [Full Text] [Related]
30. A DEFECT IN CELLULAR IMMUNITY DURING THE INCUBATION PERIOD OF PASSAGE A LEUKEMIA IN C3H MICE. DENT PB; PETERSON RD; GOOD RA Proc Soc Exp Biol Med; 1965 Jul; 119():869-71. PubMed ID: 14329023 [No Abstract] [Full Text] [Related]
36. Passive immunotherapy of leukemia and other cancer. Motta R Adv Cancer Res; 1971; 14():161-79. PubMed ID: 5001001 [No Abstract] [Full Text] [Related]
37. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen. Zola H Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121 [TBL] [Abstract][Full Text] [Related]
38. INFLUENCE OF PERITONEAL INFLAMMATORY EXUDATE ON DEVELOPMENT OF A TRANSPLANTABLE MOUSE ASCITES TUMOR. BARSKI G; BELEHRADEK J; KAWAMATA J Proc Soc Exp Biol Med; 1965 May; 119():111-4. PubMed ID: 14297819 [No Abstract] [Full Text] [Related]
39. REJECTION OF ALLOGENEIC SKIN GRAFTS AND PRODUCTION OF SPECIFIC HEMAGGLUTININS BY NONIRRADIATED AND IRRADIATED MICE SENSITIZED BY VARIOUS MEANS. TYAN ML J Immunol; 1965 Jan; 94():22-30. PubMed ID: 14253519 [No Abstract] [Full Text] [Related]
40. AGING AND CANCERIGENESIS. I. IMMUNITY TO TUMOR AND SKIN GRAFTS. TELLER MN; CURLETT W; KUBISEK ML; CURTIS D; STOHR G J Natl Cancer Inst; 1964 Oct; 33():649-56. PubMed ID: 14220248 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]